ArticleHaematologica2021

Antiplatelet properties of Pim kinase inhibition are mediated through disruption of thromboxane A2 receptor signaling.

Amanda J Unsworth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.